FIELD: microbiology.
SUBSTANCE: invention refers to pharmacy and microbiology. What is presented is the use of human serum albumin (HSA) in concentration from 49 to 71 mg/ml as an antimicrobial agent destroying microbial cells.
EFFECT: technical result consists in the purpose of: not only inhibiting growth of Escherichia coli, Candida albicans, Staphylococcus aureus, Cryptococcus neoformans, but also destruction of cells with formation of debris in physiological concentrations of HSA; invention provides the ability to use HSA as an antimicrobial agent and use it as an indicator of antimicrobial activity of blood serum in patients.
1 cl, 2 dwg, 2 tbl, 3 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF DETERMINING ANTIMICROBIAL ACTIVITY OF WHOLE SERUM AND FRACTION OF ITS ANTIMICROBIAL PEPTIDES | 2018 |
|
RU2686337C1 |
| METHOD FOR OBTAINING SPECIFIC ANTIGENIC PREPARATIONS FROM CLINICALLY SIGNIFICANT YEAST FUNGI | 2015 |
|
RU2660365C1 |
| METHOD FOR DETERMINING ANTIMICROBIAL PEPTIDE TOTAL ACTIVITY AS A MARKER OF TISSUE IMMUNITY STATE OF VARIOUS EPITHELIAL TISSUES | 2015 |
|
RU2602298C2 |
| STRAIN OF Candida albicans varietas stellatoidea FOR PRODUCING DIAGNOSTIC ALLERGEN | 2015 |
|
RU2601123C1 |
| METHOD OF DETERMINING THEOPHYLLINE IN BLOOD SERUM | 0 |
|
SU1573427A1 |
| INTERLEUKIN-2-BASE PHARMACEUTICAL PREPARATION (VARIANTS) | 1998 |
|
RU2140283C1 |
| STRAINS OF Streptococcus pneumoniae (VERSIONS) AND METHOD OF PRODUCING PROTECTIVE PROTEIN FRACTION, POSSESSING INTRASPECIFIC IMMUNOGENIC ACTIVITY | 2015 |
|
RU2601158C1 |
| METHOD OF PRODUCING FOUR-COMPONENT LIVE CULTURE VACCINE AGAINST MEASLES, VARICELLA, MUMPS, AND RUBELLA | 2019 |
|
RU2717769C1 |
| METHOD OF OBTAINING PNEUMOCOCCAL HYPERIMMUNE SERA | 2016 |
|
RU2624871C1 |
| APPLICATION OF MILKY WHEY APOPROTEINS IN PROPHYLAXIS OR TREATMENT OF MICROBIAL OR VIRAL INFECTION | 2002 |
|
RU2305547C2 |
